Skip to content

Different FiO2 induction of general anesthesia on the patients undergoing uniportal thoracoscopic surgery in the contralateral pulmonary atelectasis

Different FiO2 induction of general anesthesia on the patients undergoing uniportal thoracoscopic surgery in the contralateral pulmonary atelectasis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085525
Enrollment
Unknown
Registered
2024-06-11
Start date
2024-06-12
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing uniportal thoracoscopic surgery

Interventions

Group A(FiO2=60%):different FiO2
Group B(FiO2=80%):different FiO2
Group C(FiO2=100%):different FiO2

Sponsors

Sichuan Science City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.conform to the surgical indications and elective right lung resection;2.aged 18-65 years old;3. BMI:18 to 30 kg/m2;3. American Society of Anesthesiologists (ASA) ?-?; 4. Quit smoking for 4 weeks before surgery;5, signed informed consent, in line with medical ethics.

Exclusion criteria

Exclusion criteria: 1.FEV1)/FVC=70% of expected value;2. Preoperative SPO2 < 90% and/or PaO2 < 60mmHg 3.presence of pulmonary or respiratory tract infection;4. Severe liver, kidney and endocrine diseases;5, anemia, severe cardiovascular disease and other organ dysfunction. 6. Those who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Incidence rate of atelectasis on the contralateral sid;

Secondary

MeasureTime frame
Time of intubation;rate of SPO2 <95% during intubation;Oxygenation index at different time points;the incidence index of postoperative pulmonary complications;postoperative length of stay;

Countries

China

Contacts

Public ContactJinlong Ju

anesthesiology department,Sichuan Science City Hospital

84914669@qq.com+86 138 8009 7914

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026